Abstract: A guiding sheath has a braided layer for improved deflection characteristics and ring electrodes for electrical sensing, mapping and visualization, wherein lead wires for the ring electrodes are passed through lumened tubing position under the braided layer in a proximal portion of the guiding sheath shaft and above the braided layer in a distal portion of the guiding sheath shaft. Moreover, the hemostatic valve includes an improved friction ring with air vents to reduce the risk of air being introduced into the valve.

Abstract: A guiding sheath has a braided layer for improved deflection characteristics and ring electrodes for electrical sensing, mapping and visualization, wherein lead wires for the ring electrodes are passed through lumened tubing position under the braided layer in a proximal portion of the guiding sheath shaft and above the braided layer in a distal portion of the guiding sheath shaft. Moreover, the hemostatic valve includes an improved friction ring with air vents to reduce the risk of air being introduced into the valve.

Abstract: A guiding sheath has a braided layer for improved deflection characteristics and ring electrodes for electrical sensing, mapping and visualization, wherein lead wires for the ring electrodes are passed through lumened tubing position under the braided layer in a proximal portion of the guiding sheath shaft and above the braided layer in a distal portion of the guiding sheath shaft. Moreover, the hemostatic valve includes an improved friction ring with air vents to reduce the risk of air being introduced into the valve.

Abstract: A guiding sheath has a braided layer for improved deflection characteristics and ring electrodes for electrical sensing, mapping and visualization, wherein lead wires for the ring electrodes are passed through lumened tubing position under the braided layer in a proximal portion of the guiding sheath shaft and above the braided layer in a distal portion of the guiding sheath shaft. Moreover, the hemostatic valve includes an improved friction ring with air vents to reduce the risk of air being introduced into the valve.

Abstract: A guiding sheath has a braided layer for improved deflection characteristics and ring electrodes for electrical sensing, mapping and visualization, wherein lead wires for the ring electrodes are passed through lumened tubing position under the braided layer in a proximal portion of the guiding sheath shaft and above the braided layer in a distal portion of the guiding sheath shaft. Moreover, the hemostatic valve includes an improved friction ring with air vents to reduce the risk of air being introduced into the valve.

Abstract: A guiding sheath has a braided layer for improved deflection characteristics and ring electrodes for electrical sensing, mapping and visualization, wherein lead wires for the ring electrodes are passed through lumened tubing position under the braided layer in a proximal portion of the guiding sheath shaft and above the braided layer in a distal portion of the guiding sheath shaft. Moreover, the hemostatic valve includes an improved friction ring with air vents to reduce the risk of air being introduced into the valve.

Abstract: Treatment of aneurysmal blood vessels with local delivery of therapeutic agents thereby reduces or lessens the severity of an aneurysm, and, where used in conjunction with the placement of an excluding device, provides for more rapid recovery of the blood vessel from any disturbance occurring during placement of the excluding device. Therapeutic agents are placed in the aneurysmal site in a time-release carrier medium, such that the therapeutic agent is released into the aneurysmal site over a period of time without the need to provide systemic introduction of the therapeutic agent. The carrier may be introduced through the patient's dermis, such as with the use of a laparoscope, or intravascularly, through the use of a catheter. The carrier may be in a solid matrix, viscous liquid or liquid form.

Abstract: Treatment of aneurysmal blood vessels with local delivery of therapeutic agents thereby reduces or lessens the severity of an aneurysm, and, where used in conjunction with the placement of an excluding device, provides for more rapid recovery of the blood vessel from any disturbance occurring during placement of the excluding device. Therapeutic agents are placed in the aneurysmal site in a time-release carrier medium, such that the therapeutic agent is released into the aneurysmal site over a period of time without the need to provide systemic introduction of the therapeutic agent. The carrier may be introduced through the patient's dermis, such as with the use of a laparoscope, or intravascularly, through the use of a catheter. The carrier may be in a solid matrix, viscous liquid or liquid form.

Abstract: A medical device delivery system and method of manufacture that includes an outer catheter, a first inner catheter insertable through the outer catheter, and a second inner catheter insertable through the first inner catheter and adapted to receive a guidewire extending there through. The first inner catheter includes a braided reinforcement layer and is adapted to receive an elongated medical device extending there through.

Abstract: Treatment of aneurysmal blood vessels with local delivery of therapeutic agents thereby reduces or lessens the severity of an aneurysm, and, where used in conjunction with the placement of an excluding device, provides for more rapid recovery of the blood vessel from any disturbance occurring during placement of the excluding device. Therapeutic agents are placed in the aneurysmal site in a time-release carrier medium, such that the therapeutic agent is released into the aneurysmal site over a period of time without the need to provide systemic introduction of the therapeutic agent. The carrier may be introduced through the patient's dermis, such as with the use of a laparoscope, or intravascularly, through the use of a catheter. The carrier may be in a solid matrix, viscous liquid or liquid form.

Abstract: Treatment of aneurysmal blood vessels with local delivery of therapeutic agents thereby reduces or lessens the severity of an aneurysm, and, where used in conjunction with the placement of an excluding device, provides for more rapid recovery of the blood vessel from any disturbance occurring during placement of the excluding device. Therapeutic agents are placed in the aneurysmal site in a time-release carrier medium, such that the therapeutic agent is released into the aneurysmal site over a period of time without the need to provide systemic introduction of the therapeutic agent. The carrier may be introduced through the patient's dermis, such as with the use of a laparoscope, or intravacularly, through the use of a catheter. The carrier may be in a solid matrix, viscous liquid or liquid form.

Abstract: A medical device delivery system and method of manufacture that includes an outer catheter, a first inner catheter insertable through the outer catheter, and a second inner catheter insertable through the first inner catheter and adapted to receive a guidewire extending there through. The first inner catheter includes a braided reinforcement layer and is adapted to receive an elongated medical device extending there through.

Abstract: An endoluminal stent graft includes a healing-promoting material to enhance the “healing” of the proximal and/or distal neck(s) of the endoluminal stent graft and the vessel wall; the risk of migration and the occurrence of Type 1 endoleaks is reduced. The healing-promoting material is located within a proximal anchor region located near the proximal neck opening of the endoluminal stent graft and optionally within one or more distal anchor regions located near one or more distal neck openings of the endoluminal stent graft.

Abstract: An excluding device is inserted in a vessel. An excluded space is formed between a portion of a wall of the vessel and a portion of an exterior surface of the excluding device. A treatment element is passed through a channel of the excluding device into the excluded space. The channel is sealed using a cuff or patch after the passing of the treatment element(s) such as fill material or drugs and drug releasing elements.

Abstract: A delivery system for delivering a sensor to a body cavity includes a catheter and sheath slidably or rotatably coupled to the catheter. The sheath may be retractable and peelable. The delivery device may include an expandable balloon or a crushable material capable of moving the sensor laterally away from the catheter, to the target site. One embodiment of the delivery system includes a deployment device comprising a cord operably engaged with a pulley, and attached at the distal end to a cap engaged with the sensor. Another embodiment of the delivery system comprises a catheter having a chamber that can accommodate the sensor, and a sheath slidably coupled to the exterior of the catheter, and covering the chamber when the sheath is in the closed position. Further included is a method of delivering a sensor to a body cavity using any of the embodiments of the delivery system.

Abstract: A semi-directional drug delivery stent for selectively delivering one or more therapeutic agents to an area of interest within a bodily or luminal structure is disclosed. In one embodiment, a semi direction drug delivery stent includes a generally cylindrical body defining at least one internal passage positioned longitudinally therein, a non-permeable material applied to the cylindrical body, and at least one therapeutic agent applied to the at least one of the cylindrical body and the non-permeable material.

Abstract: Methods and apparatus for minimizing the risks inherent in endovascular grafting for aneurysm repair are provided, including the implantation and time-controlled release of at least one bioactive agent at the aneurysmal site.

Abstract: A delivery system for delivering a sensor to a body cavity includes a catheter and sheath slidably or rotatably coupled to the catheter. The sheath may be retractable and peelable. The delivery device may further include an expandable balloon or a crushable material capable of moving the sensor laterally away from the catheter, to the target site. One embodiment of the delivery system includes a deployment device comprising a cord operably engaged with a pulley, and attached at the distal end to a cap, the cap being engaged with the sensor to be delivered. Another embodiment of the delivery system comprises a catheter having a chamber that can accommodate the sensor, and a sheath slidably coupled to the exterior of the catheter, and covering the chamber when the sheath is in the closed position. Further included in the present invention is a method of delivering a sensor to a body cavity using any of the embodiments of the delivery system.

Abstract: Treatment of aneurysmal blood vessels with local delivery of therapeutic agents thereby reduces or lessens the severity of an aneurysm, and, where used in conjunction with the placement of an excluding device, provides for more rapid recovery of the blood vessel from any disturbance occurring during placement of the excluding device. Therapeutic agents are placed in the aneurysmal site in a time-release carrier medium, such that the therapeutic agent is released into the aneurysmal site over a period of time without the need to provide systemic introduction of the therapeutic agent. The carrier may be introduced through the patient's dermis, such as with the use of a laparoscope, or intravacularly, through the use of a catheter. The carrier may be in a solid matrix, viscous liquid or liquid form.

Abstract: An aneurysm filling system includes a guide catheter, a delivery tubing containing a plurality of embolizing units of an embolizing material, and a pushrod within said delivery tube. The pushrod pushes the embolizing units out of the delivery tubing once the delivery tube has been guided through the guide catheter to a delivery position. A method for treating an aneurysm includes deploying an endoluminal prosthesis and an embolizing material adjacent the aneurysm. The embolizing material is expanded to fill a portion of the aneurysm. The endoluminal prosthesis retains the expanded embolizing material within the aneurysm. A vascular implant system for treating an aneurysm includes an endoluminal prosthesis, a guide catheter including a delivery tubing slidably carried therein, and an embolizing material positioned within the delivery tubing. The embolizing material expands and fills a portion of the aneurysm when deployed from the delivery tubing.